Asset Details
Do you wish to reserve the book?
Emerging opportunistic yeast infections
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Emerging opportunistic yeast infections
Do you wish to request the book?
Emerging opportunistic yeast infections
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Emerging opportunistic yeast infections
2011
Overview
A growing population of immunosuppressed patients has resulted in increasingly frequent diagnoses of invasive fungal infections, including those caused by unusual yeasts. The incidence of non-albicans species of
Candida is increasing compared with that of
Candida albicans, and several species, such as
Candida glabrata and
Candida krusei, may be resistant to azole antifungal therapy.
Trichosporon species are the second most common cause of fungaemia in patients with haematological malignant disease and are characterised by resistance to amphotericin and echinocandins and poor prognosis.
Rhodotorula species belong to the family Cryptococcaceae, and are a cause of catheter-related fungaemia, sepsis, and invasive disease in severely immunosuppressed patients. An increasing number of sporadic cases of invasive fungal infections by non-neoformans cryptococci have been reported in immunocompromised hosts, especially for patients with advanced HIV infection or cancer who are undergoing transplant. Other uncommon yeasts that can cause invasive disease in severely immunosuppressed patients include
Geotrichum, Hansenula, Malassezia, and
Saccharomyces. Host immune status is a crucial determinant of the type of invasive fungal infection a patient is at risk for. Diagnosis can be challenging and relies heavily on traditional cultures of blood and other sterile sites, although serum (1,3)-β-D-glucan testing might have an adjunctive role. Although rare yeasts are emerging as opportunistic human pathogens, diagnosis remains challenging and treatment suboptimal.
Publisher
Elsevier Ltd,Lancet Publishing Group,Elsevier Limited
Subject
/ Biological and medical sciences
/ Blood
/ Cancer
/ Clinical Laboratory Techniques - methods
/ Communicable Diseases, Emerging - diagnosis
/ Communicable Diseases, Emerging - drug therapy
/ Communicable Diseases, Emerging - epidemiology
/ Communicable Diseases, Emerging - microbiology
/ Fungi - growth & development
/ Fungi - isolation & purification
/ Human immunodeficiency virus
/ Humans
/ Mycoses
/ Opportunistic Infections - diagnosis
/ Opportunistic Infections - drug therapy
/ Opportunistic Infections - epidemiology
/ Opportunistic Infections - microbiology
/ Sepsis
/ Yeasts
